PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

 

Friday August 28, 2009

PennyOmega.com Stock Report!

**************************************************************

The Farmers National Bank of Emlenton, the subsidiary operating bank of Emclaire Financial Corp. (OTCBB: EMCF), announced today that the Bank completed its acquisition of the full-service branch office of National City Bank (”National City”), now a part of The PNC Financial Services Group, Inc. (NYSE: PNC), located in Titusville, Pennsylvania. The office will open for full service as a Farmers National Bank office on Monday, August 31, 2009.

Seamless Corporation (OTCBB: SMWF) announced today that it and one of America’s favorite product promoters, Dr. Gadget, further solidified their relationship by Seamless’ acquisition of www.gadgetenterprises.com, an eCommerce website. Terms

...

Since I last wrote about Access Pharma [ACCP: 0.00, N/A (N/A)] two weeks ago as a cancer biotech call option trade, the Company has issued two updates on its clinical development pipeline and two updates for MuGard – which is an oral rinse product for the management of a common side effect of many cancer therapies, mucositis. In late May, Access announced that MuGard was launched in Germany, Italy, UK, Greece, and the Nordic countries by its European commercial partner, SpePharm, with expected launches in North America, Asia, and other regions slated for later this year. On 6/10/09, ACCP.OB also announced that the Company received issue notifications from the United States Patent and Trademark Office for two US patents (numbers 7,544,348 and 7,547,433).

A video presentation is available at ProActiveNewsRoom.com for MuGard, in addition to more information and links at the landing page

...

Access Pharmaceuticals Inc., an emerging biopharmaceutical company, is focused on developing novel nanopolymer delivery technologies and products for cancer and dermatology. Currently, the company has one approved product, one product in phase 3 clinical development, four products in phase 2, and six products in preclinical development.

Although Access’ primary focus is on oncology and supportive care of cancer patients, the company has acquired product candidates in the dermatology field as well as additional oncology assets. The business development team is interested in identifying out-licensing candidates, as well as alliance and merger opportunities for the company’s oncology and dermatology products, as well as nanopolymer technologies.

In most recent news, Access announced that it has received issue notifications from the United States Patent and Trademark Office that two US patents relating to MuGard TM , the company’s approved oral rinse product for the management of mucositis, will issue this month. MuGard is a ready-to-use

...

The cancer biotech space has attracted the interest of investors, traders, and diversified healthcare giants this year with Johnson & Johnson [JNJ: 55.50, +0.34 (+0.62%)] announcing a $1B cash tender offer for Cougar Biotech [CGRB: 42.87, -0.12 (-0.28%)] last week and Roche’s [ROG: 17.67, +0.61 (+3.58%)] [RHHBY: 0.00, N/A (N/A)] mega-deal to acquire full control of Genentech earlier this year. In addition, positive clinical trial results for Dendreon’s [DNDN: 23.2099, +0.5399 (+2.38%)] Provenge and stock price turnarounds from the brink of zero at Cell Therapeutics [CTIC: 1.60, +0.17 (+11.89%)] have fueled interest in the small and micro-cap cancer bio-pharma space among investors and traders looking for the next big trade.

Access Pharma [ACCP: 0.00, N/A (N/A)] is an emerging bio-pharma company which is focusing on the development of a late-stage, diversified oncology pipeline in addition to

...

by Manuel Alvarez-Rivera, Puerto Ricobr /br /Just two years after holding a A HREF="http://globaleconomydoesmatter.blogspot.com/2007/05/iceland-2007-parliamentary-election.html"parliamentary election/A, voters in Iceland are likely to return to the polls next May 9 for an early general election. Normally, the poll would not need to be held until 2011, but these are anything but normal times in the Nordic island nation, whose economy has been devastated by the ongoing global financial crisis.br /br /With all of Iceland's three major banks under receivership since October; the national currency (the krona) having lost over half its value and the stock market over 90 percent of its value; inflation and unemployment on the rise; and the GDP expected to contract by ten percent this year, public discontent over the perceived mismanagement of the economy by the coalition government of Iceland's two major parties - the conservative Independence Party and the left-of-center Social Democratic Alliance - has fueled mounting ...

The IMF finally announced it's Latvia "bailout" plan on Friday. The plan involves lending about €1.7 billion ($2.4 billion) to Latvia to stabilise the currency and financial support while the government implements its economic adjustment plan. The loan, which will be in the form of a 27-month stand-by arrangement, is still subject to final approval by the IMF's Executive Board but is likely to be discussed before the end of this year under the Fund's fast-track emergency financing procedures, and it is not anticipated that there will be any last minute hitches (although I do imagine some eyebrow raising over the decision to support the continuation of the Lat peg). The Latvian government admits that some of the IMF economists involved in the negotiations advocated a devaluation of the lat as a way of ammeliorating the ...

In our November 19 post, we said we are monitoring five key dimensions on ten key asset categories to gauge when, how and how much to commit the cash we raised in the summer to the markets in the future.

1. Technical Market Factors 2. Valuation Fundamentals 3. Risk Levels 4. Government Intervention Policies 5. Economic Conditions

Ten Key Asset Categories Relative Performance Since Oct 1:

click image to enlarge

Headlines Re - Government Policies and Economic Conditions:

The headlines in the financial press over the last 24 hours, clearly show that our 4th and 5th monitoring dimensions are not near to being settled enough to risk cash. Consider this headlines sample:

Nov 19 (Financial Times) — Junk bond yields spike — Average yields on US junk bonds have topped 20 per cent for the first time amid rising concerns about a protracted

...

Trading Theme returns…  Automakers’ bailout vote today…  Not using all your arrows…  Housing Starts go back to 1959! And Now… Today’s Pfennig!

OK… Whew! What an awful day yesterday for the currencies… In the morning, they ere in rally mode with the euro gaining ground to well within the 1.27 handle. But then the Trading Theme set in, and those gains were wiped out. The Trading Theme was set off by the awful Housing data, which reminded everyone of the deep, dark , dangerous days ahead… I bought some euros, and watched them rise, and went off to do something else… When I returned, they had fallen… UGH! The Japanese yen, however, rallied, as is the case with the Trading Theme… Risk trades get unwound, which benefits dollars, and yen. I’ve explained all this before, so I won’t get into it again, but there’s someone that has gone into the problems

...